Markets & MarketsAutomation & Drug ScreeningSLAS opens with 409 exhibitors and 6,700 a...The world’s most important conference for laboratory automation and drug screening tools, SLAS 2025 International, opens today in San Diego. One of the highlights will be the pitches for the best start-up, … more ➔
Wuxi BiologicsPartnershipSwiss AB2 Bio inks US$ 686m license option...Nippon Shinyaku has secured an option to acquire exclusive US rights to commercialize AB2 Bio’s tadekinig alfa to treat primary monogenic IL-18 driven hyperinflammatory syndrome in patients with NLRC4 … more ➔
Project EadenMeat alternativesProject Eaden bags €15m to scale up prod...Berlin-based food tech start-up Project Eaden is prepared to launch its first plant-based ham product by mid-year in 2,000 REWE supermarkets. A oversubscribes Series A financing laid the basis for this … more ➔
Adobe Stock - whitehoune FinancingCeres Brain Therapeutics announces €6m f...Paris-based drug delivery specialist Ceres Brain Therapeutics SA has raised €6m led by ANJAC, a French family-owned industrial group and preferred partner of healthcare laboratories and beauty and … more ➔
Arctic TherapeuticsFinancingArctic Therapeutics ASA kicks off with €...Iceland’s Arctic Therapeutics has secured €26.5m in a Series A financing aimed to push its oral drug candidates AT-O01 and AT-004 into clinical trails in patients with rare amyloid aggregation diseases … more ➔
EU ParliamentBiologisation of industryEuropaBio calling for EU Biotech ActEuropaBio calls for an ambitious cross-sectoral EU Biotech Act, that strengthens Europe as a global biotechnology leader for competitiveness and strategic autonomy. more ➔
adobe stock.com - HomuGallery EMAPRAC: Semaglutide linked to rare eye disea...The Safety Committee PRAC of the European Medicines Agency EMA is investigating a new potential adverse reaction to the appetite suppressant semaglutide. Epidemiological studies indicate that the rare … more ➔
InflaRx Acute Respiratory Distress SyndromeInflaRx secures European Commission approv...Jena-based InflaRx has reached a significant milestone with the European Commission’s approval of GOHIBIC (Vilobelimab), a novel anti-C5a monoclonal antibody for the treatment of SARS-CoV-2-induced … more ➔
David_SMC from PixabayInfectious diseaseSynairgen raises £18m for Phase 2 INVENT...Synairgen plc (SNG) has announced the successful completion of a £18m funding round, primarily supported by TFG Asset Management. The funding will advance the Phase 2 INVENT trial, assessing SNG001, … more ➔
By Vaccinationist - PubChem, WikipediaIntra-CellularJohnson & Johnson acquires Intra-Cell...Johnson & Johnson has announced the acquisition of biopharmaceutical company Intra-Cellular Therapies, strengthening its position in the market for central nervous system disorder treatments. The $14.6 … more ➔
Markets & Markets
Wuxi Biologics
Project Eaden
Adobe Stock - whitehoune 
Arctic Therapeutics
EU Parliament
adobe stock.com - HomuGallery 
InflaRx 
David_SMC from Pixabay
By Vaccinationist - PubChem, Wikipedia